Jacobs-Led Biologics Manufacturing Facility Nabs Top Industrial Project Honor
Our work on Bristol-Myers Squibb’s new Large-Scale Cell Culture Biologics manufacturing facility in Ireland topped the list in the Industrial category at this year’s Irish Construction Excellence Awards.
We are delighted to have topped the Industrial Category at the for our work on Bristol-Myers Squibb’s new Large-Scale Cell Culture Biologics manufacturing facility in Dublin, Ireland.
Jacobs provided architecture, engineering, construction management and turnover services on the new facility, which will manufacture immuno-oncology medicines for Bristol-Myers Squibb (BMS). Immuno-oncology represents an innovative approach to cancer treatment that seeks to harness the body’s own immune system to fight tumor cells.
Located in Cruiserath County, Dublin, Ireland, the LSCC facility will manufacture immuno-oncology medicines for BMS. Immuno-oncology represents an innovative approach to cancer treatment that seeks to harness the body’s own immune system to fight tumor cells.
We delivered this important project within budget, applying state‐of‐the‐art project/construction management techniques and tools throughout the project life‐cycle – and achieving an impressive safety record on more than 6,500,000 site hours. of the fast‐track program.
“I am delighted to accept this award on behalf of the dedicated Jacobs team who supported this ambitious project for BMS. At its peak, we had over 2,200 people on site, with over 6,500,000 site hours worked to an extremely fast-track program. The project was delivered safely, within budget and on schedule, employing state‐of‐the‐art project/construction and management techniques and tools,” said Jacobs Ireland Vice President and General Manager Micheál O’Connor, commenting on the award. “Most importantly, the facility will provide a powerful, life-saving cancer treatment to patients in Ireland and globally. This is a great achievement not only for Jacobs, but also for BMS and the supply chain we employed.”
The ICE Awards were presented at a gala dinner event in Dublin on Friday March 29th.
In addition to the BMS LSCC Biologics manufacturing facility, Jacobs is also involved with several other impactful projects across Ireland, including serving on the consortium , central to a new multi-modal transport strategy to support Dublin's continued economic growth.